Caro Health

Overview

Caro Health is an AI-powered digital health company based in Amsterdam, Netherlands, known for enhancing patient care through conversational AI technology. Founded in 2019 by Thomas Goijarts and Guusje van der Heijden, the company aims to streamline communication between healthcare providers and patients, thereby optimizing the patient journey and improving healthcare outcomes. As of 2025, Caro Health has been acquired by the Healthcare Outcomes Performance Company (HOPCo), a move set to expand its reach on a global scale and integrate with HOPCo's digital health platforms.

Recent Developments

August 2025: Caro Health was acquired by HOPCo, a move aimed at integrating Caro's AI-driven platforms into HOPCo's global operations. This acquisition enhances HOPCo's digital health capabilities, specifically in musculoskeletal (MSK) care, and broadens its European footprint.
July 2025: Caro Health introduced digital consent processes at Esser Clinics, reducing paperwork and enhancing patient preparation.
June 2025: The Future-proof pain rehabilitation at CIR project was introduced with the CIR App and AI chat from Caro Health, focusing on client-oriented care.
May 2025: Caro Health expanded its presence in hospitals and clinics across Europe, supporting almost 40 healthcare organizations with its AI capabilities.
2024: Caro Health worked on integrating AI-powered translations and smart chat suggestions to make healthcare interactions more efficient and personal.
2023: The company successfully renewed its NEN 7510 and ISO 27001 certifications, reaffirming its commitment to data security and privacy in healthcare.

Attribute	Information
Founding Date	2019
Headquarters	Amsterdam, Netherlands
Founders	Thomas Goijarts, Guusje van der Heijden
Revenue	Not publicly disclosed
Profits	Not publicly disclosed
Key Investors	HOPCo
Industry	Digital Health, AI Technology
Number of Employees	1-10

Early History

Caro Health was founded in 2019 by Thomas Goijarts and Guusje van der Heijden, with a focus on leveraging AI technology to transform patient care. The company started by developing a platform that integrates with Electronic Health Record (EHR) systems to provide a seamless digital health experience. Initially serving healthcare providers in the Netherlands and Belgium, Caro Health quickly gained traction due to its innovative approach to personalized patient communication. Significant early milestones include securing partnerships with various healthcare institutions and integrating its AI solutions into existing healthcare workflows.

Company Profile and Achievements

Caro Health's business model revolves around providing AI-driven solutions to enhance patient-provider communication. The company's proprietary platform uses conversational AI to reduce administrative burdens and improve the quality of patient interactions. Notable achievements in its short history include:

Integration with EHR Systems: Caro Health significantly improved interoperability within healthcare settings, allowing seamless data exchange and automation.
Expansion Across Europe: Within five years of its founding, Caro Health expanded its solutions to nearly 40 healthcare organizations across Belgium, the Netherlands, and beyond.
ISO 27001 and NEN 7510 Certifications: The company reaffirmed its commitment to data security by obtaining crucial quality and security certifications.
Technological Innovations: Launched features such as AI chat widgets and smart chat suggestions, which have enhanced patient engagement and streamlined clinical workflows.

Current Operations and Market Position

Caro Health continues to operate at the forefront of digital health innovation, now as a key part of HOPCo's Digital Health Division. Its technology is pivotal in reducing administrative tasks for healthcare professionals and improving patient outcomes through enhanced communication pathways. The acquisition by HOPCo further elevates its market position by providing resources for scaling operations and expanding its technology's reach globally. Caro Health's impact is particularly notable in the musculoskeletal care sector, where its AI solutions help streamline provider-patient interactions.

Conclusion

Caro Health has established itself as a pioneer in digital health innovation through its cutting-edge conversational AI technology. By focusing on improving communication within healthcare settings, Caro Health has not only optimized patient journeys but has also increased operational efficiencies for healthcare providers. The acquisition by HOPCo marks a significant milestone, enabling the company to extend its innovative solutions globally while reinforcing its presence in the European market. As Caro Health integrates with HOPCo's global platform, it is well-positioned to continue driving advancements in patient-centered care and value-based healthcare solutions.